| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $91K | +1205.7% |
| Cost of Revenue | $127K | +86.1% |
| Gross Profit | -$36K | +41.1% |
| R&D Expense | $0 | — |
| SG&A Expense | $645K | +120.4% |
| Operating Income | -$2.6M | -207.9% |
| Interest Expense | $115K | +19.4% |
| Net Income | -$2.8M | -216.8% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $9K | +399.3% |
| Accounts Receivable | $25K | — |
| Inventory | $178K | +2014.3% |
| Current Assets | $214K | +1995.4% |
| Total Assets | $394K | +3755.3% |
| Current Liabilities | $2.0M | +5.5% |
| Total Liabilities | $2.2M | +10.0% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$1.8M | -434.7% |
| Capital Expenditures | $55K | — |
| Investing Cash Flow | -$55K | — |
| Financing Cash Flow | $1.9M | +450.3% |
| Free Cash Flow | -$1.9M | -450.7% |
| Stockholders' Equity |
| -$1.8M |
| +9.2% |